ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Condition: Hereditary Transthyretin Amyloidosis (hATTR)

In The News Burden of Illness Among Patients with Hereditary Transthyretin (hATTR) Amyloidosis
In The News Epidemiology of Hereditary Transthyretin (hATTR) Amyloidosis: A Real-World Analysis of a US Commercially Insured Population
In The News Epidemiology of Hereditary Transthyretin (hATTR) Amyloidosis: A Real-World Analysis of a US Commercially Insured Population
In The News Untangling Hospitalizations in Systemic Amyloidosis: Patient Characteristics, Economic Cost, and Clinical Outcomes
In The News Healthcare Utilization and Cost Among Patients with Hereditary Transthyretin Amyloidosis (hATTR)
In The News Disease Burden of Hereditary Transthyretin Amyloidosis (hATTR): Analysis of Real-World Data

Posts pagination

< Previous page 1 2
© 2026
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health